Moreover, one study showed that the efficacy of bone marrow-derived MSCs is dependent on their passage number, particularly noting that high-passage cells exhibited better survival and greater neuroprotective effects (likely due to the upregulation of neurotrophic factors, like BDNF) when transplanted intrastriatally in a mouse model of HD [366]. The gene discussed is BDNF; the disease is Huntington disease.